SCHEDULE 13D:ORIGINAL FILING

Company

ImmunityBio, Inc.

Filed

August 31, 2015

Accession Number

0001193125-15-308271

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →